CHEPLAPHARM’s €750 Million High Yield Bond Offering

Latham & Watkins advised CHEPLAPHARM on the offering.CHEPLAPHARM Arzneimittel GmbH announced the issuance of €750 million aggregate principal amount of New York law 144A/Reg S senior secured…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now